1.
Kaplan DT, Furman MI, Pincus SM. Techniques for Analyzing
Complexity in Heart Rate and Beat to Beat Blood Pressure
Signals. Computers in Cardiology, 1991.
2.
Kaplan DT, Furman MI, Pincus SM, Ryan SM, Lipsitz
LA, Goldberger AL. Aging and the Complexity of Cardiovascular
Dynamics. Biophys J 59: 945-49, 1991
3.
Ivanhoe, RJ, Weintraub WS, Douglas JS Jr., Lembo NJ, Furman
M, Gershony G, Cohen CL, King SP III, Percutaneous Transluminal
Coronary Angioplasty Of Chronic Total Occlusions: Primary
Success, Restenosis, And Long Term Clinical Follow-Up. Circulation
85;106-15, 1992.
4.
Goldschmidt-Clermont PJ, Furman MI, Wachstock D,
Safer D, Nachmias VT, Pollard TD. The Control of Actin Nucleotide
Exchange by Thymosinb4 and Profilin. A Potential Regulatory
Mechanism for Actin Polymerization in Cells. Molec Biol
Cell 3:1015-24 1992.
5.
Furman MI, Gardner TM, Goldschmidt-Clermont PJ. Mechanisms
of Cytoskeletal Reorganization during Platelet Activation.
Thromb and Haemost 70 229-232.1993.
6.
Furman MI, Grigoryev D, Bray PF, Dise KR Goldschmidt-Clermont.
Platelet Tyrosine Kinases and Fibrinogen Receptor Activation.
Circ Res 75:172-80, 1994.
7.
Furman MI, Becker RC, Yarzbeski J, Savageau J. Gore
JM, Goldberg RJ. Effect of Elevated Leukocyte Count on In-Hospital
Mortality Following Acute Myocardial Infarction. Am J Cardiol
78:945-48, 1996.
8.
Michelson AD, Benoit SE. Furman MI, Breckwoldt WL.,
Rohrer MJ, Barnard MR, Loscalzo J. Effects of Endothelium-derived
Relaxing Factor/Nitric Oxide on Platelet Surface Glycoproteins.
Am J of Phys (Heart and Circulatory Physiology): 270:H1640-48,
1996
9.
Michelson AD, Benoit SE, Furman MI, Barnard MR, Nurden
P, Nurden AT. The Platelet Surface Expression of Glycoprotein
V is Regulated by Two Independent Mechanisms: Proteolysis
and a Reversible Cytoskeletal-mediated Redistribution to
the Surface-connected Canalicular System. Blood 87:1396-1408,
1996
10.
Sharma M, Furman MI, Spencer FA, Burns M, Ball SP,
Becker, RC. Thrombolytic Therapy in Acute Myocardial Infarction:
Management Algorithms J Thromb Thromboly, 4:397-413, 1997.
11.
Sharma M, Furman MI, Spencer FA, Burns M, Ball SP,
Becker, RC. Current and Practical Management of Acute Myocardial
Infarction. J Thromb Thrombolys , 4: 375-396 1997
12.
Furman MI, Liu L, Benoit SE, Becker RC, Barnard MR,
Michelson, AD. The Cleaved Peptide of the Thrombin Receptor
is a Strong Platelet Agonist. Proc Natl Acad Sci, U.S.A.
95:3082-87, 1998
13.
Furman MI, Benoit SE, Valeri CR, Borbone ML, Becker
RC, Hechtman HB, Michelson AD. Increased Platelet Reactivity
and Circulating Platelet-Monocyte Aggregates in Patients
with Stable Coronary Artery Disease. J Am Coll Cardiol 31:352-8,
1998
14.
Peyton BR, Rohrer MJ Furman MI, Barnard MR, Rodino
LJ, Benoit SE, Hechtman HB, Valeri CB, and Michelson AD.
Patients with venous stasis ulceration have increased monocyte-platelet
aggregation. J Vasc Surg 27:1109-15, 1998.
15.
Michelson AD and Furman MI Laboratory Markers of
Platelet Activation and Their Clinical Significance. Curr
Opin Hematol 6:342-348, 1999.
16.
Powell CC, Rohrer MJ, Barnard MR, Peyton BD, Furman MI,
and Michelson AD. Chronic Venous Insufficiency is Associated
with Increased Platelet and Monocyte Activation and Aggregation.
J Vasc Surg 30:844-51, 1999.
17.
Furman MI. Markers of Platelet Activation. J Thromb
Thromboly 9:81-84, 2000.
18.
Michelson AD, Furman MI, Goldschmidt-Clermont P,
Mascelli MA, Hendrix C, Coleman L, Hamlington J, Barnard
M, Kickler T, Christie DJ, Kundu S, and Bray PJ. Platelet
GPIIIa PLA Polymorphisms Display Different Sensitivity to
Agonists. Circulation 101:1013-18, 2000.
19.
Michelson AD, Barnard MR, Krueger LA, Frelinger AL, and
Furman MI. Evaluation of Platelet Function by Flow
Cytometry Methods. A Companion to Methods in Enzymology
21:259-70. 2000.
20.
Simon DI, Chen Z, Xu H, Li CQ, Dong J, McIntire LV, Ballantyne
CM, Zhang L, Furman MI, Berndt MC, Lopez JA. Platelet
Glycoprotein Iba Is A Counter-Receptor for Leukocyte Integrin
Mac-1 (CD11b/CD18). J Exp Med 192:193-204, 2000.
21.
Michelson AD, Barnard MR, Krueger LA, Frelinger III AL,
Furman MI. Evaluation of platelet function by flow
cytometry. Purdue Cytometry. CD ROM volume 5, 2000.
22.
Michelson AD, Barnard MR, Krueger LA, Frelinger III AL,
Furman MI. Evaluation of platelet function by flow
cytometry. Methods 21: 259-70, 2000.
23.
Furman MI, Frelinger, AL and Michelson AD. Antithrombotic
Therapy in the Cath Lab. Current Cardiology Reports 2:386-394,
2000.
24.
Dauerman HL, Yarzebski J, Lessard D, Furman MI, Gore
JM, and Goldberg RJ. TenYear Trends in the Incidence, Treatment
and Outcome of Q Wave Myocardial Infarction: A Population
Based Perspective. Am J Cardiol 86:730-735, 2000.
25.
Furman MI, Krueger LA, Frelinger AL, Barnard MR,
Mascelli MA, Nakada MT, and Michelson AD. GPIIb-IIIa Antagonist-induced
Reduction in Platelet Surface Factor V/Va Binding and Phosphatidylserine
Expression in Whole Blood. Thromb and Haemost 84:492-8,
2000.
26.
Furman MI, Nurden P, Berndt MC, Nurden AT, Benoit
SE, Liu L, Rohrer MR, Barnard MR, and Michelson, AD. The
Cleaved Peptide of PAR1 Results in a Redistribution of Platelet
Surface GPIb to the Surface-Connected Canalicular System.
Thromb and Haemost 84:897-903, 2000.
27.
Claytor BR, Li J-M, Furman MI, Garnette CSC, Rohrer
MJ, Barnard MR, Krueger LA, Frelinger AL, Michelson AD.
Laser scanning cytometry: a novel method for the detection
of platelet-endothelial cell adhesion. Cytometry 43:308-313,
2001.
28.
Furman MI, Dauerman HL, Goldberg RJ, Yarzbeski J,
Lessard D, and Gore JM. Twenty-Two Year (1975-1997) Trends
in the Incidence, In-Hospital and Long-Term Case-Fatality
Rates from Initial Q Wave and Non-Q Wave Myocardial Infarction:
A Multi-Hospital, Community-Wide Perspective. J Am Coll
Cardiol 37:1571-80, 2001.
29.
Michelson AD, Barnard MR, Krueger LA, Frelinger AL, and
Furman MI. Flow cytometry and other methods for the
detection of circulating activated platelets. In Gresele
P, Page CP, Vermylen J, Fuster V (eds). Platelets in Thrombotic
and Non-Thrombotic Disorders: Pathophysiology, Pharmacology,
and Therapeutics. Cambridge University Press, Cambridge,
in press, 2001
30.
Bray PF, Goldschmidt-Clermont P, Furman MI, Michelson
AD, Barnard MR, Mascelli MA, Hendrix C, Coleman L, Hamlington
J, Kickler T, Christie DF, and Kundu S. Platelet glycoprotein
IIIa PlA polymorphism and effects of aspirin on thrombin
generation. Circulation 103:e33-e34, 2001 (letter).
31.
Michelson AD, Barnard MR, Krueger LA, Valeri CR and Furman
MI. Circulating Monocyte-Platelet Aggregates Area More
Sensitive Marker of Platelet Activation Than Platelet Surface
P-Selectin: Studies in Baboons, Human Coronary Intervention,
and Human Myocardial Infarction Circulation 104:1533-1537,
2001
32.
Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale
EA, Lessard DM, Marchese P, Frelinger III, AL, Goldberg
RJ, and Michelson AD. Circulating Monocyte-Platelet Aggregates
are an Early Marker of Acute Myocardial Infarction. J Am
Coll Cardiol 38:1002-1006, 2001.
33.
Frelinger AL, Furman MI, Krueger LA, Barnard MR,
and Michelson AD. Dissociation of glycoprotein IIb/IIa antagonists
from platelets does not result in fibrinogen binding or
platelet aggregation. Circulation 104:1374-1379, 2001
34.
Furman MI, Kereiakes DJ, Krueger LA, Mueller MN,
Pieper K, Broderick TM, Schneider JF, Howard L, Fox ML,
Barnard MR, Frelinger AL, and Michelson AD. Leukocyte-Platelet
Aggregation, Platelet Surface P-Selectin, and Platelet Surface
GPIIIa Following Percutaneous Coronary Intervention: Effects
of Dalteparin or Unfractionated Heparin in Combination with
Abciximab. Am Heart J 142:790-798, 2001
35.
Michelson AD, Barnard MR, Krueger LA, Frelinger AL, and
Furman MI. Flow cytometry and other methods for the
detection of circulating activated platelets. In Gresele
P, Page CP, Fuster V, Vermylen J (eds). Platelets in Thrombotic
and Non-Thrombotic Disorders: Pathophysiology, Pharmacology,
and Therapeutics. Cambridge University Press, Cambridge,
in press, 2001
36.
Krueger LA, Barnard MR, Frelinger AL, Furman MI,
and Michelson AD. Immunophenotypic analysis of platelets.
In Robinson JP, Darzynkiewicz Z, Dean P, Orfao A, Rabinovitch
P, Tanke H, Wheeless L (eds). Current Protocols in Cytometry.
John Wiley & Sons, New York, in press, 2002.
37.
Michelson AD, Barnard MR, Krueger LA, Frelinger AL, and
Furman MI. Flow cytometry. In Michelson AD (ed).
Platelets. Academic Press, New York, 297-319, 2001.
38.
Krueger LA, Barnard MR, Frelinger AL, III, Furman MI,
and Michelson AD. Immunophenotypic analysis of platelets.
In Robinson JP, Darzynkiewicz Z,Dean PN, Dressler LG, Rabinovitch
PS, Stewart CC, Tanke HJ, Wheeless LL(eds). Current Protocols
in Cytometry. John Wiley & Sons, New York,1:6.10.1-6.10.17,
2002.
39.
Wheeler GL, Braden GA, Kereiakes DJ, Kottke-Marchant K,
Michelson AD, Furman MI, Mueller M, Moliterno DJ,
and Sane DC. The Accumetrics Ultegra-RPFA: a study of equivalence
to standard platelet function assays in patients undergoing
percutaneous coronary intervention with abciximab therapy.
Submitted for publication.
40.
Marciniak SJ, Mascelli MA, Furman MI, Michelson AD,
Jakubowski JA, Jordan RE, and Frelinger AL. An additional
mechanism of action of abciximab: dispersal of newly formed
platelet aggregates. Thromb Haemost 87:1020-5, 2002.
41.
Frelinger AL, Furman MI, Krueger LA, Barnard MR,
and Michelson AD. Activating effects of GPIIb/IIIa blockers:
an intrinsic consequence of ligand-mimetic properties. Response.
Circulation 105:180e-181e, 2002 (letter).
42.
Furman MI, Kereiakes DJ, Krueger LA, Mueller MN,
Broderick TM, Schneider JF, Howard WL, Fox ML, Barnard MR,
Frelinger AL, and Michelson AD. Quantification of abciximab-induced
platelet inhibition is assay dependent: A comparative study
in patients undergoing percutaneous coronary intervention.
in press, Am Heart J: 2002.
43.
Rashkin, J and Furman MI. Long term trends in fatality
rates from myocardial infarction. in press Cardiovasc Rev
Reports: 2003.
44.
Rohrer MJ, Claytor RB, Garnette CSC, Powell CC, Barnard
MR, Furman MI, and Michelson AD. Platelet-monocyte
aggregates in patients with chronic venous insufficiency
remain elevated following correction of reflux. Submitted
for publication.
45. Garnette CSC, Barnard MR, Furman MI, Rohrer MJ,
Frelinger AL, Claytor RB, Krueger LA, and Michelson AD.
Proteolysis of platelet surface P-selectin and disaggregation
of leukocyte-platelet complexes by cathepsin G. Submitted
for publication.
46.
Furman MI, Frelinger AL, and Michelson AD. GPIIb/IIIa
Inhibitor-induced Dethrombosis. Submitted to Circulation.
47.
Furman MI, Gore JM, Anderson FA, Budaj A, Goodman
SG, Avezum A, MD3, López-Sendón J, Klein W, Mukherjee D,
Eagle KA, Dabbous OH, and Goldberg RJ for the GRACE Investigators.
Relationship Between Elevated Leukocyte Count and Hospital
Events in Patients with Acute Coronary Syndromes: Findings
from the Global Registry of Acute Coronary Events (GRACE).
Submitted for publication, J Am Coll Cardiol.
